Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.11717 http://scihub22266oqcxt.onion/10.18632/oncotarget.11717 C5342606!5342606 !27589834     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27589834 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Oncotarget 2016 ; 7 (43 ): 71013-71035 Nephropedia Template TP {{tp|p=27589834 |t=2016. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer |pdf=|usr=}}{{27589834 }} gab.com Text Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=27589834 #FOAvip Personalized medicine has emerged as the future of cancer care to ensure that patients receive individualized treatment specific to their needs. In order to provide such care, molecular techniques that enable oncologists to diagnose, treat, and monitor tumors are necessary. In the field of lung cancer, cell free DNA (cfDNA) shows great potential as a less invasive liquid biopsy technique, and next-generation sequencing (NGS) is a promising tool for analysis of tumor mutations. In this review, we outline the evolution of cfDNA and NGS and discuss the progress of using them in a clinical setting for patients with lung cancer. We also present an analysis of the role of cfDNA as a liquid biopsy technique and NGS as an analytical tool in studying EGFR and MET, two frequently mutated genes in lung cancer. Ultimately, we hope that using cfDNA and NGS for cancer diagnosis and treatment will become standard for patients with lung cancer and across the field of oncology. Twit Text FOAVip Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=27589834 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27589834 #FOAvip English Wikipedia <ref>{{Cite pmid|27589834 }}</ref> Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer #MMPMID27589834 Bennett CW ; Berchem G ; Kim YJ ; El-Khoury V Oncotarget 2016[Oct]; 7 (43 ): 71013-71035 PMID27589834 show ga Personalized medicine has emerged as the future of cancer care to ensure that patients receive individualized treatment specific to their needs. In order to provide such care, molecular techniques that enable oncologists to diagnose, treat, and monitor tumors are necessary. In the field of lung cancer, cell free DNA (cfDNA) shows great potential as a less invasive liquid biopsy technique, and next-generation sequencing (NGS) is a promising tool for analysis of tumor mutations. In this review, we outline the evolution of cfDNA and NGS and discuss the progress of using them in a clinical setting for patients with lung cancer. We also present an analysis of the role of cfDNA as a liquid biopsy technique and NGS as an analytical tool in studying EGFR and MET, two frequently mutated genes in lung cancer. Ultimately, we hope that using cfDNA and NGS for cancer diagnosis and treatment will become standard for patients with lung cancer and across the field of oncology. |Biomarkers, Tumor/blood [MESH] |Cell-Free Nucleic Acids/genetics/*isolation & purification [MESH] |DNA Mutational Analysis/methods [MESH] |DNA, Neoplasm/*isolation & purification [MESH] |ErbB Receptors/genetics [MESH] |High-Throughput Nucleotide Sequencing [MESH] |Humans [MESH] |Liquid Biopsy/methods [MESH] |Lung Neoplasms/*blood/diagnosis/*pathology/therapy [MESH] |Mutation [MESH] |Precision Medicine/*methods [MESH]Cell-free DNA and next-generation sequencing in the service of persona(epmc).pdf DeepDyve Pubget Overpricing